Literature DB >> 23921679

Development of an in-house enzyme-linked immunosorbent assay based on surface whole cell antigen for diagnosis of Helicobacter pylori infection in patients with gastroduodenal ulcer disease.

Faisal Aziz1, Sikander Khan Sherwani, Syed Shakeel Akhtar, Shahana Urooj Kazmi.   

Abstract

Helicobacter pylori (H. pylori) is a causative agent of gastritis, gastroduodenal ulcers and gastric adenocarcinoma. More than 50% world population is colonized by H. pylori, which is closely related to the chronic gastritis and gastric ulcer infection. In this study, a total of 214 gastritis patient's serum samples were screened for anti-H. pylori IgG antibody. A 96-well plate coated with 20 μg/ml antigen and hundred-fold diluted patient's serum was allowed to react. After extensive washing with buffer, 1:2,500 diluted conjugated secondary antibody was added. Later substrate was added to observe positivity by measuring the intensity of color. Statistical analyses were performed, and p value of <0.01 was taken as significant; 84% male patients and 89% female patients, respectively, tested positive for H. pylori, while agewise distribution was 35-45 years males (40%) and 35-55 years females (52%) were found highest number of H. pylori infected patients. In-house ELISA based on surface whole cell antigen (wELISA) showed a sensitivity of 93%, specificity of 100%, accuracy 94% and κ value 0.86 with significant correlation R-0.77020; p < 0.0001. We conclude that H. pylori local isolates surface antigen was satisfactory for diagnosis as different parameters were adjusted according to the local H. pylori isolates. Fluctuations in serum antibody titer predict the variation in an individual's response of the host against H. pylori. In-house wELISA could provide a reliable and a clinically useful method for the diagnosis of H. pylori infection in patients of Karachi, Pakistan.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921679     DOI: 10.1007/s11274-013-1448-4

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  41 in total

Review 1.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 2.  Helicobacter pylori vaccine development: facing the challenge.

Authors:  Toni Aebischer; Andrea Schmitt; Anna K Walduck; Thomas F Meyer
Journal:  Int J Med Microbiol       Date:  2005-09       Impact factor: 3.473

3.  Selection and interpretation of diagnostic tests and procedures. Principles and applications.

Authors:  P F Griner; R J Mayewski; A I Mushlin; P Greenland
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

4.  Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.

Authors:  Chandrabali Ghose; Guillermo I Perez-Perez; Victor J Torres; Marialuisa Crosatti; Abraham Nomura; Richard M Peek; Timothy L Cover; Fritz Francois; Martin J Blaser
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

5.  Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique.

Authors:  L P Andersen; F Espersen
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation.

Authors:  S Hayashi; T Sugiyama; K Yokota; H Isogai; E Isogai; K Oguma; M Asaka; N Fujii; Y Hirai
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Seroprevalence of Helicobacter pylori infections in Thailand.

Authors:  G I Perez-Perez; D N Taylor; L Bodhidatta; J Wongsrichanalai; W B Baze; B E Dunn; P D Echeverria; M J Blaser
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies.

Authors:  L P Andersen; F Espersen; A Souckova; M Sedlackova; A Soucek
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Enzyme-linked immunosorbent assay for Helicobacter pylori needs adjustment for the population investigated.

Authors:  Thi Thu Ha Hoang; Thuc-Uyen Wheeldon; Carina Bengtsson; Dac Cam Phung; Mikael Sörberg; Marta Granström
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  Non-invasive diagnosis of H pylori infection: evaluation of serological tests with and without current infection marker CIM.

Authors:  Sufi-H Z Rahman; M-Golam Azam; M-Anisur Rahman; M-S Arfin; M-Mahbub Alam; Tareq-M Bhuiyan; Nasim Ahmed; Motiur Rahman; Shamsun Nahar; M-S Hassan
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

View more
  8 in total

1.  Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.

Authors:  Faisal Aziz; Xuesong Yang; Xiaoqi Wang; Qiu Yan
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-20       Impact factor: 4.553

2.  Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α.

Authors:  Faisal Aziz; Xiang Li; Abhijit Chakraborty; Yaqiu Zheng; Mingxia Xin; Kangdong Liu; Zigang Dong
Journal:  Gastric Cancer       Date:  2022-05-07       Impact factor: 7.701

Review 3.  Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer.

Authors:  Faisal Aziz; Abhijit Chakraborty; Imran Khan; Josh Monts
Journal:  Biology (Basel)       Date:  2022-02-06

4.  Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.

Authors:  Faisal Aziz; Wei Gao; Qiu Yan
Journal:  Pathol Oncol Res       Date:  2016-10-18       Impact factor: 3.201

5.  Assessment of the diagnostic accuracy and relevance of a novel ELISA system developed for seroepidemiologic surveys of Helicobacter pylori infection in African settings.

Authors:  Evariste Tshibangu-Kabamba; Bui Hoang Phuc; Vo Phuoc Tuan; Kartika Afrida Fauzia; Augustin Kabongo-Tshibaka; Nadine Kalenda Kayiba; Angel Rosas-Aguirre; Brecht Devleesschauwer; Alain Cimuanga-Mukanya; Patrick de Jésus Ngoma Kisoko; Takashi Matsumoto; Junko Akada; Ghislain Tumba Disashi; Dieudonné Mumba Ngoyi; Yasutoshi Kido; Niko Speybroeck; Yoshio Yamaoka
Journal:  PLoS Negl Trop Dis       Date:  2021-09-09

Review 6.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

7.  Prevalence and correlation with clinical diseases of Helicobacter pylori cagA and vacA genotype among gastric patients from Northeast China.

Authors:  Faisal Aziz; Xin Chen; Xuesong Yang; Qiu Yan
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

8.  Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and DFMO Treatment, Respectively.

Authors:  Faisal Aziz; Mingxia Xin; Yunfeng Gao; Abhijit Chakroborty; Imran Khan; Josh Monts; Kjersten Monson; Ann M Bode; Zigang Dong
Journal:  Cancers (Basel)       Date:  2020-03-28       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.